Oncology Peer Review On-The-Go: Treatment Considerations for Transplant-Ineligible Multiple Myeloma

Podcast

CancerNetwork®’s podcast dives into an article focused on treatment options for older, transplant-ineligible patients with multiple myeloma.

The feature article for this episode comes from the April issue of the journal ONCOLOGY® titled “Treatment Considerations for Transplant-Ineligible Multiple Myeloma.” Sarah A. Holstein, MD, PhD, an associate professor of internal medicine in the Division of Oncology & Hematology at University of Nebraska Medical Center in Omaha, spoke about the need for further research into treatment options for the older and frailer patient population of multiple myeloma.

Holstein also explained the importance of understanding results from multiple myeloma clinical trials through the lens of how they apply to this specific transplant-ineligible population.

Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.

Recent Videos
4 experts are featured in this series.
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.
3 experts in this video
3 experts in this video
2 experts are featured in this series.
9 Experts are featured in this series.
Related Content